Rep. Waxman Becomes Key Legislator On Biopharma Issues With House Flip
This article was originally published in The Pink Sheet Daily
Executive Summary
The congressman will likely support follow-on biologics legislation and other reforms sought by the generic industry as chairman of Government Reform Committee and as a senior member of Energy & Commerce Committee.